Dylan Lawless

Intensive Care and Neonatology, Swiss Pediatric Sepsis Study and SwissPedHealth: CHF 6M, seven hospitals, approximately 1,000 patients, over 100 TB of genomic, multi-omic, clinical, and EHR-linked data.

Global Health Institute, EPFL (Fellay lab). Translational genomics and precision medicine, with a focus on statistical genomics, rare disease, host–pathogen interactions, and development of reproducible multi-omics pipelines used in national research efforts.

School of Medicine, University of Leeds (Savic lab). Genetic discovery in rare primary immunodeficiencies using genome sequencing and functional validation in clinical cohorts.

ACM Global Laboratories. Regulatory-compliant biomarker validation, assay development, and support for clinical trials.

EPFL (Ablasser lab), intracellular innate immunity, cGAS–STING signalling, and antiviral sensing mechanisms. Trinity College Dublin (Bowie lab), viral immunology and innate immune evasion by poxviruses. University College Cork (Morgan lab), innate immune responses in macrophages, bacterial infection, and inflammasome biology.

Discovery of novel inborn errors of immunity Led genomic discovery and functional characterisation of multiple inborn errors of immunity, including autoinflammatory disease of the NF-κB pathway involving MEFV and TNFAIP3 (A20), and immunodeficiency caused by pathogenic variation in RAG1 and RAG2 a

Advanced theoretical immunology and practical research projects. Exploring the therapeutic potential of a peptide derived from a poxviral immune evasion protein.